In terms of tissue-based biomarkers, tumor PD-L1 expression is used as an established diagnostic marker in patients with non-small cell lung cancer (NSCLC) [7] in addition to breast, head, and neck cancer patients [8,9]. Here, CD274 is linked to non-small cell lung carcinoma.